Animal & cell studies
BPC-157
Tendon-cell movement, vascular receptor signalling and gastrointestinal injury models give BPC-157 a predominantly preclinical tissue-biology literature.
Research Library
Peptide Research Library UK
Explore published peptide studies, scientific findings and PubMed references, organised by compound to make research easier to navigate.
23 compounds65 PubMed sources
Research entries
23 research entries
Combination study in rats
BPC-157 + TB-500
A rat tendon comparison found no added effect from combining BPC-157 with TB-500. Component mechanisms provide context alongside that non-additive finding.
Component research
CJC-1295 + Ipamorelin
The individual components approach growth-hormone signalling through GHRH and ghrelin-receptor pathways. Component pharmacology supplies context for the blend, rather than a measured combined effect.
Human, animal & cell studies
CJC-1295 with DAC
Albumin binding extends CJC-1295 exposure. Short human studies recorded sustained GH and IGF-I responses while preserving pulse structure.
Analytical & peptide research
CJC-1295 without DAC
Position-2 modification, enzymatic stability and sample-specific identity analysis help explain the no-DAC GHRH analogue’s research context.
Human & animal studies
DSIP
DSIP’s early human sleep observations sit alongside conflicting animal findings and an unresolved endogenous signalling role.
Human, animal & cell studies
GHK-CU
GHK-Cu research spans matrix synthesis, turnover and copper-dependent cell responses. A tiny human trial found objective null results despite greater self-reported skin improvement.
Component research
GLOW
The individual components contribute matrix, vascular and actin-related research themes. Their separate findings do not demonstrate a finished GLOW effect.
Cellular & biochemical research
Glutathione
GSH cycling, protein-thiol chemistry and sample redox preservation connect glutathione’s biochemical role with the interpretation of laboratory measurements.
Structural & cell research
IGF-1 LR3
LR3 structure and binding-protein comparisons explain how its apparent potency changes with the cell environment. Native IGF-I findings remain separate pathway context.
Animal & cell studies
Ipamorelin
Relative endocrine selectivity, pituitary adaptation and rat bone-size findings illuminate different parts of ipamorelin pharmacology.
Component research
KLOW
KPV adds uptake and inflammatory-signalling questions to the individual components’ matrix, vascular and actin-related themes. The finished KLOW blend remains a separate research question.
Animal & cell studies
KPV
PepT1-dependent cell uptake links KPV with NF-κB and MAP-kinase measurements. Engineered delivery adds a separate mouse-colitis research context.
Human studies
L-Carnitine
Transport biology explains cellular carnitine availability. Human supplementation findings range from small null trials to modest, variable pooled metabolic changes.
Human studies
Melanotan I
Human afamelanotide implant trials provide formulation-specific evidence in photosensitivity and alongside vitiligo phototherapy.
Human studies
Melanotan II
Small Melanotan II pilots recorded pigmentation and other physiological responses alongside systemic adverse observations.
Animal & cell studies
MOTS-C
Metabolic and nuclear-stress experiments connect mitochondrial peptide origin with AMPK and transcriptional responses in cells and mice.
Cellular & biochemical research
NAD+
Redox cycling, enzyme consumption and tissue-specific turnover explain why one whole-cell NAD measurement cannot capture all of its biology.
Human & cell studies
Pinealon
EDR cell experiments found specific DNA-damage and dendritic changes alongside unchanged ageing-related measurements. The human combination report is much weaker.
Human, animal & cell studies
Selank
Transcriptional and enzyme observations complement small Selank clinical comparisons without establishing selective GABA-receptor agonism.
Human & animal studies
Semax
Regional BDNF–TrkB findings and mixed human neurological observations give Semax a more specific context than a broad cognitive claim.
Full-length & fragment research
TB-500
Full-length thymosin β4 actin and cell-migration research is distinguished from short TB-500 fragment identity and metabolism. A tiny eye-drop trial adds formulation-specific human context.
Human studies
Tesamorelin
An N-terminal modification changes tesamorelin stability. Clinical preparations have been studied with visceral-fat, liver-fat and endocrine endpoints in defined HIV-associated populations.
No matching research found.
For laboratory research use only. Content is provided for research reference and is not intended as medical or veterinary guidance.